AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL

Clinical trial NCT07215585 · RECRUITING

Trial details

NCT number: NCT07215585
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Large B-cell Lymphoma

Start date: 2025-11-11
Primary completion: 2030-06-10
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.